Kirkland advised Teva, while Baker McKenzie and Herzog, Fox & Neeman advised the underwriters on the offering. Teva Pharmaceutical Industries Limited executed a $5 billion (equivalent) (upsized...
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here